EUVIMED · CrossrefJournal
In Silico Research in Biomedicine
ISSN 3050-7871 · Elsevier BV
Latest articles
Quinazoline-Containing Derivatives as Potential Modulators of TSLP and IL-33: Computational Evidence from Molecular Docking, Molecular Dynamics Simulations, MM/PBSA Binding Energy Estimation, and ADME Prediction
Computational Investigation of Metformin-Glimepride Complex: Electronic Structure, Non-Covalent Interactions, Spectroscopic Properties, and Molecular Dynamics Insights
Computational Profiling of Verminoside at DNMT1, CDK2, and p15INK4b: A Shared-Pathway Approach to AML, MDS, and Ewing Sarcoma
In Silico Modelling of Pharmacological Profiles and ADMET Properties via Advanced Machine Learning Approach
A descriptive framework for dose-resolved transcriptomic analysis reveals heterogeneous responses of Pseudomonas aeruginosa PAO1 to CuO nanoparticles
Computational Design and In Silico Immune Profiling of a Broad-Coverage Circular mRNA Vaccine Candidate against SARS-CoV-2
Receptor-Conditioned Prediction and Threshold-Based Prioritization for Multi-Receptor Molecular Design
Potential diagnostic markers and therapeutic targets for major depressive disorder based on bioinformatics analysis and molecular docking studies
Docking simulations and multi-parameter ADMET profiling to decode quinapyramine sulfate’s strength and weakness
In silico approach to identify berberine-derived from Arcangelisia flava (L.) Merr as potential inhibitor for antimalarial
Uncovering Zika virus-specific neurodevelopmental disruptions through deep learning and transcriptomic profiling of human neural cells
Targeting a key virulence factor in Listeria monocytogenes: An in silico discovery and pharmacokinetic profiling of novel internalin H inhibitors
Gene expression profiling of sex-specific differences in systemic lupus erythematosus morbidity
In-silico repurposing of imeglimin against Alzheimer’s disease using network pharmacology, molecular docking and molecular dynamic simulations approaches
Structure-based virtual screening, quantum chemical calculations, and ADMET-based scaffold hopping of dual inhibitors targeting respiratory syncytial and influenza a viruses
One health in action: Structure-based drug repurposing for porcine delta and epidemic diarrhea viruses
Machine learning-based dual-target prediction models for EGFR/ROS1 and PDGFR/c-KIT inhibitors
Integrated computational biology revealed ellagic acid exerts antioxidant and anticancer activities through inhibition of ROS-induced JNK/p38 MAPK kinase pathway
The role of Marburg virus glycoprotein diversity on epitopes conservation and its impact on effectiveness of vaccines and therapeutic antibodies: A call for one health strategy in vaccines research, development, and coordinated implementation
Molecular mechanism and multi-target inhibitory property of ruxolitinib as potential anti-SARS-CoV-2 agent: Network pharmacology study combined with molecular docking, molecular dynamics simulation and MM-PB(GB)SA analysis
Unveiling the structural and retrosynthetic mechanism of some 2-aziridinyl- and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate compounds as treatment of malaria parasite, Plasmodium falciparum: MD simulation, binding free energy calculation, and thermodynamic studies
In silico disruption of TGF-β signalling in AR-deficient triple-negative breast cancer via AMP-based therapeutics
In silico identification of benzamide-based aryl halides as EGFR inhibitors: multi-ligand ADMET, pharmacophore mapping, and target prediction
From data to diagnosis: Heart disease likelihood prediction using six integrated datasets and rigorous evaluation of some machine learning models for Android app deployment
Molecular modeling and optimization of pyranoquinolinone derivatives as potential DNA gyrase inhibitors for typhoid fever treatment: A Comprehensive QSAR, molecular docking, ADMET, and molecular dynamics simulation studies
Targeting G and F proteins of human metapneumovirus: An in silico strategy for multiepitope vaccine design
Design, modelling, and pharmacokinetic prediction of novel BRD4-targeting PROTACs
RETRACTED: Investigating the potential therapeutic compounds of Equisetum ramosissimum Desf. against uropathogenic Escherichia coli through molecular docking, MD simulation, ADMET and toxicity predictions
A novel framework for assessing large language models in computational drug design: Targeting AXL receptor tyrosine kinase for cancer therapy
Identifying novel therapeutic targets for glioblastoma: Insights from plasma proteome analysis
EUVIMED